The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk

被引:34
作者
Drenos, F.
Whittaker, J. C.
Humphries, S. E.
机构
[1] UCL Royal Free & Univ Coll Med, Ctr Cardiovasc Genet, Dept Med, British Heart Fdn Labs, London WC1E 6JF, England
[2] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England
关键词
meta-analysis; candidate genes; coronary heart disease; risk; odds ratio; 10 year risk; APOB; NOS3; APOE; ACE; SERPINE1; MTHFR; ITGA2B; PON; 1; LPL; CETP;
D O I
10.1111/j.1469-1809.2007.00359.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although the risk for coronary heart disease (CHD) associated with single SNPs is modest it has been suggested that, in combination, several common risk-associated alleles could lead to a substantially better heart disease risk prediction. We have modelled this using 10 SNPs in ten candidate genes (APOB, NOS3, APOE, ACE, SERPINE1, MTHFR, ITGA2B, PON 1, LPL, and CETP) and their predicted summary risk estimates from meta-analysis. Based on published allele frequencies, similar to 29% of the general population would be expected to carry less than three risk alleles, approximately 55% would carry 3 or 4 risk alleles, 4% would have 6 and 1% 7 or more risk alleles. Compared to the mean of those with 3 or 4 risk associated genotypes, those with 6 and 7-or-more alleles have a significantly higher risk odds ratio (OR) of CHD (mean OR (95% Confidence Intervals), 1.70 (1.14 to 2.55); and 4.51 (2.89 to 7.04) respectively), while compared to those in the lowest decile of risk, those in the highest decile have a CHD odds ratio in the range of 3.05 (2.24 to 4.14). Taking into account age and the risk alleles carried, the mean 10 year probability for developing CHD for a 55 year old man was calculated to be 15% (8.6% to 24.8%), with nearly 1 in 5 having more than 20% risk. Whether this particular group of 10 SNPs will improve the accuracy of CHD predictions over the combination of classical risk factors in clinical use requires further experimental evidence.
引用
收藏
页码:611 / 619
页数:9
相关论文
共 24 条
[1]   Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].
Assmann, G ;
Cullen, P ;
Schulte, H .
CIRCULATION, 2002, 105 (03) :310-315
[2]   Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - Individual patient meta-analysis of 13,677 subjects [J].
Boekholdt, SM ;
Sacks, FM ;
Jukema, JW ;
Shepherd, J ;
Freeman, DJ ;
McMahon, AD ;
Cambien, F ;
Nicaud, V ;
de Grooth, GJ ;
Talmud, PJ ;
Humphries, SE ;
Miller, GJ ;
Eiriksdottir, G ;
Gudnason, V ;
Kauma, H ;
Kakko, S ;
Savolainen, MJ ;
Arca, M ;
Montali, A ;
Liu, S ;
Lanz, HJ ;
Zwinderman, AH ;
Kuivenhoven, JA ;
Kastelein, JJP .
CIRCULATION, 2005, 111 (03) :278-287
[3]   Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction [J].
Boekholdt, SM ;
Bijsterveld, NR ;
Moons, AHM ;
Levi, M ;
Büller, HR ;
Peters, RJG .
CIRCULATION, 2001, 104 (25) :3063-3068
[4]   Endothelial nitric oxide synthase genotype and ischemic heart disease - Meta-analysis of 26 studies involving 23028 subjects [J].
Casas, JP ;
Bautista, LE ;
Humphries, SE ;
Hingorani, AD .
CIRCULATION, 2004, 109 (11) :1359-1365
[5]   Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies [J].
Casas, JP ;
Cooper, J ;
Miller, GJ ;
Hingorani, AD ;
Humphries, SE .
ANNALS OF HUMAN GENETICS, 2006, 70 :145-169
[6]   APO B gene polymorphisms and coronary artery disease: a meta-analysis [J].
Chiodini, BD ;
Barlera, S ;
Franzosi, MG ;
Beceiro, VL ;
Introna, M ;
Tognoni, G .
ATHEROSCLEROSIS, 2003, 167 (02) :355-366
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study [J].
Cooper, JA ;
Miller, GJ ;
Humphries, SE .
ATHEROSCLEROSIS, 2005, 181 (01) :93-100
[9]   Is homocysteine an independent risk factor for cardiovascular disease? [J].
Domínguez-Rodríguez, A ;
Abreu-González, P ;
García-González, MJ ;
Ferrer-Hita, J .
MEDICINA CLINICA, 2005, 125 (20) :798-799
[10]   Genetic testing for cardiovascular disease susceptibility: A useful clinical management tool or possible misinformation? [J].
Humphries, SE ;
Ridker, PM ;
Talmud, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :628-636